Delivery Order SPE2DB20D2104-SPE2DB24FU77K

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.38 firm-fixed-price delivery order is for the supply of GLIPIZIDE ER 10 MG TABLET 1000S, a generic diabetes medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,826.38 firm fixed-price delivery order is for the supply of GLIPIZIDE ER 10 MG TABLET 500S, a medication used to treat diabetes. The contract has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIPIZIDE ER 10 MG TABLET 500S. The $4,912.99 firm fixed-price delivery order has a completion date of November 12, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,882.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4565134640 - GLIPIZIDE ER 10 MG TABLET 1000S, with an ultimate completion date of July 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,514.11, is for the supply of 4566825852 - GLIPIZIDE ER 10 MG TABLET 500S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 3, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. In addition to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,094.42, is for the delivery of GLIPIZIDE ER 5 MG TABLET 1000S, a generic medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order under contract SPE2DX15D1205 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,509.18 award is for 1,000 tablets of Glipizide ER 10 mg, a medication used to treat diabetes. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,911.01 fixed-price contract is for the supply of Glipizide ER 10 mg tablets, a medication used to treat diabetes. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,564,804,911 tablets of Glipizide ER 10 mg, a medication used to treat type 2 diabetes. The $2,641.54 firm fixed price delivery order was issued under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,561.10 firm fixed-price delivery order is for the supply of GLIPIZIDE ER 10 MG TABLET 500S, a generic medication used to treat diabetes. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU77K
    Delivery Order

This federal contract award is a delivery order valued at $3,873.93 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIPIZIDE ER 10 MG TABLET 1000S, a medication used to treat diabetes. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no mention of any major subcontractors in the provided information.

Generated 5/17/25, 9:54 AM